Information  X 
Enter a valid email address

Merian Chrysalis Inv (MERI)

  Print      Mail a friend

Tuesday 16 April, 2019

Merian Chrysalis Inv

Result of Placing under Placing Programme

RNS Number : 2710W
Merian Chrysalis Investment Co. Ltd
16 April 2019



16 April 2019


Merian Chrysalis Investment Company Limited (the "Company")


Result of Placing under Placing Programme


Further to the announcement made by the Company on 26 March 2019, the Company today announces that it has successfully raised gross proceeds of £100 million pursuant to the Placing. The Board and the Investment Adviser are pleased with the strong response to the Placing which will allow the Company to continue to invest in the exciting opportunities within the pipeline sourced by the Investment Adviser.


Accordingly, an aggregate of 90,909,091 new Ordinary Shares have been issued and allotted conditionally upon admission at a price of 110 pence per share (the "Placing Price").


Applications have been made for the admission of 90,909,091 new Ordinary Shares to listing on the premium listing segment of the Official List and to trading on the Main Market of London Stock Exchange Group plc ("Admission"). It is expected that Admission will become effective and that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 18 April 2019.


Following Admission, the Company will have 190,909,091 Ordinary Shares in issue. Therefore, the total number of voting rights of the Company will be 190,909,091 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company.


Terms not defined in this announcement shall have the same meaning as the defined terms in the announcement on 26 March 2019.


Richard Watts, Co-fund manager, commented:


"We are delighted by the level of demand from both existing and new investors. The Chrysalis proposition is resonating strongly with late-stage, private companies that are seeking new investors as they look to evolve their shareholder base, as evidenced by our ability to quickly deploy the initial Chrysalis launch proceeds." 

Nick Williamson, Co-fund manager, commented:

"The growing opportunity for crossover investing in the UK and across Europe is compelling. Investors have recognised this and the new funds that they have provided will allow us to continue to pursue our exciting pipeline of opportunities."



For further information, please contact:


Merian Global Investors:

Will Gold



+44 (0) 20 7332 7500


Gillian Martin / Christopher Britton


Zeus Capital:

John Goold / Ben Robertson



+44 (0) 20 3100 2222



+44 (0) 20 3829 5000


Maitland Administration (Guernsey) Limited:

Aimee Gontier / Elaine Smeja


+44 (0) 1481 749364


A copy of the Prospectus is available for inspection at: as well as on the Company's website at


A copy of this announcement will be available on the Company's website at Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.


Terms used but not defined in this announcement shall have the meanings given to such terms in the Prospectus.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.


LEI: 213800F9SQ753JQHSW24


Important Notice


This announcement has been issued by and is the sole responsibility of the Company. Liberum Capital Limited ("Liberum") and Zeus Capital Limited ("Zeus Capital"), each of which are authorised and regulated by the Financial Conduct Authority in the United Kingdom, are acting only for the Company in connection with the matters described in this announcement and are not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of each of them or advice to any other person in relation to the matters contained herein. Neither Liberum, Zeus Capital nor any of its or their respective affiliates, directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.


This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US person (as defined under Regulation S under the US Securities Act). The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.


Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom and the Republic of Ireland), Canada, Australia or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe any such restrictions.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t